Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 4, 2009, Pages 1808-1813

  Ellis, Dorette Z ^a   Dismuke, William M ^a   Chokshi, Binna M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE ALPHA; GUANYLATE CYCLASE BETA; HETERODIMER; ISOENZYME; NITRIC OXIDE; UNCLASSIFIED DRUG; 1-HYDROXY-2-OXO-3,3-BIS(2-AMINOETHYL)-1-TRIAZENE; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CELL RECEPTOR; ENZYME INHIBITOR; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; SOLUBLE GUANYLYL CYCLASE; TRIAZENE DERIVATIVE;

ANIMAL CELL; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CELL FRACTIONATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURINE SYNTHESIS; TRABECULAR MESHWORK; ADULT; AGED; ANIMAL; AQUEOUS HUMOR; CULTURE TECHNIQUE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; SECRETION; SWINE; WESTERN BLOTTING;

ADULT; AGED, 80 AND OVER; ANIMALS; AQUEOUS HUMOR; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CYCLIC GMP; ENZYME ACTIVATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; ORGAN CULTURE TECHNIQUES; OXADIAZOLES; QUINOXALINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SWINE; TRABECULAR MESHWORK; TRIAZENES;

EID: 64049108719     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2750     Document Type: Article

References (40)

1. Kaufman PL. Aqueous humor outflow. Curr Top Eye Res. 1984;4: 97-138.
2. Lutjen-Drecoll E. Functional morphology of the trabecular mesh-work in primate eyes. Prog Retin Eye Res. 1999;18:91-119.
3. Maepea O, Bill A. The pressures in the episcleral veins, Schlemm's canal and the trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp Eye Res. 1989;49:645-663.
4. Johnson M, Shapiro A, Ethier CR, et al. Modulation of outflow resistance by the pores of the inner wall endothelium. Invest Ophthalmol Vis Sci. 1992;33:1670-1675.
5. Ethier CR, Croft MA, Coloma FM, et al. Enthacrynic and acid effects on inner wall pores in living monkeys. Invest Ophthalmol Vis Sci. 1999;40:1382-1391.
6. Acott TS, Kingsley PD, Samples JR, et al. Human trabecular mesh-work organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100.
7. Krupin T, Civan MM. Physiological basis of aqueous humor formation. In: Ritch R, Shields MB, eds. The Glaucomas. St. Louis: Mosby; 1995:251-280.
8. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E, et al. Biochemical and morphological analysis of basement membrane component expression in corneoscleral and cribriform human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:794-801.
9. Dismuke WM, Mbadugha CC, Ellis DZ. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am J Physiol Cell Physiol. 2008;294:C1378-C1386.
10. Stumpff F, Wiederholt M. Regulation of trabecular meshwork contractility. Ophthalmologica. 2000;214:33-53.
11. Selbach JM, Gottanka J, Wittmann M, et al. Efferent and afferent innervation of primate trabecular meshwork and scleral spur. Invest Ophthalmol Vis Sci. 2000;41:2184-2191.
12. Sugita A, Nishida H, Yoshioka H. Innervation of trabecular mesh-work. Jpn J Ophthalmol. 1986;30:257-265.
13. Tamm ER, Rohen JW, Schmidt K, et al. Superior cervical ganglionectomy in monkeys: light and electron microscopy of the anterior eye segment. Exp Eye Res. 1997;65:31-43.
14. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther. 1992;260:956-965.
15. Schneemann A, Dijkstra BG, van den Berg TJ, et al. Nitric oxide/ guanylate cyclase pathways and flow in anterior segment perfusion. Graefe's Arch Clin Exp Ophthalmol. 2002;240:936-941.
16. Kotikoski H, Vapaatalo H, Oksala O. Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits. Curr Eye Res. 2003;26:119-123.
17. Bartels SP, Lee SR, Neufeld AH. Forskolin stimulates cyclic AMP synthesis, lowers intraocular pressure and increases outflow facility in rabbits. Curr Eye Res. 1982;2:673-681.
18. Garbers DL. Purification of soluble guanylate cyclase from rat lung. J Biol Chem. 1979;254:240-243.
19. Wedel B, Harteneck C, Foerster J, et al. Functional domains of soluble guanylyl cyclase. J Biol Chem. 1995;270:24871-24875.
20. Foerster J, Harteneck C, Malkewitz J, et al. A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. Eur J Biochem. 1996;240:380-386.
21. Arnold WP, Mittal CK, Katsuki S, et al. Nitric oxide activates guanylate cyclase and increases guanosine 3:5 -cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA.1977;74:3203-3207.
22. Pang IH, Shade DL, Clark AF, et al. Preliminary characterization of a transformed cell strain derived from human trabecular mesh-work. Curr Eye Res. 1994;13:51-63.
23. Stamer WD, Seftor RE, Williams SK, et al. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
24. Stamer WD, Roberts BC, Howell DN, et al. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
25. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture: a new method. Invest Ophthalmol Vis Sci. 1987;28:945-953.
26. Erickson-Lamy K, Rohen JW, Grant WM. Outflow facility studies in the perfused bovine aqueous outflow pathways. Curr Eye Res. 1988;7:799-807.
27. Overby D, Gong H, Qiu G, et al. The mechanism of increasing outflow facility during washout in the bovine eye. Invest Ophthalmol Vis Sci. 2002;43:3455-3464.
28. Erickson-Lamy K, Schroeder AM, Bassett-Chu S, et al. Absence of time-dependent facility increase ("washout") in the perfused enucleated human eye. Invest Ophthalmol Vis Sci. 1990;31:2384-2388.
29. Bachmann B, Birke M, Kook D, et al. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47:2011-2020.
30. Ellis DZ, Nathanson JA, Rabe J, et al. Carbachol and nitric oxide inhibition of Na, K-ATPase activity in bovine ciliary processes. Invest Ophthalmol Vis Sci. 2001;42:2625-2631.
31. Ellis DZ, Nathanson JA, Sweadner KJ. Carbachol inhibits Na -K -ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway. Am J Physiol. 2000;279:C1685-C1693.
32. Zhou L, Thompson WJ, Potter DE. Functional identification of phosphodiesterase activity in human trabecular meshwork cells. J Ocul Pharmacol Ther. 2000;16:317-322.
33. Kee C, Kaufman PL, Gabelt BT. Effect of 8-Br cGMP on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci. 1994;35: 2769-2773.
34. Miller MR, Okubo K, Roseberry MJ, et al. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries. J Cardiovasc Pharmacol. 2004;43:440-451.
35. Krupin T, Weiss A, Becker B, et al. Increased intraocular pressure following topical azide or nitroprusside. Invest Ophthalmol Vis Sci. 1977;16:1002-1007.
36. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol. 1998;358:113-122.
37. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci. 1995;36: 1765-1773.
38. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprus-side and nitric oxide: evidence for the involvement of S-nitroso-thiols as active intermediates. J Pharmacol Exp Ther. 1981;218: 739-749.
39. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2002;99:8306-8311.
40. Sydow K, Daiber A, Oelze M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest. 2004;113:482-489.